Клинические результаты применения иммуномодулятора в комплексном лечении пациентов с асептическим панкреонекрозом
М В Варганов, С Н Стяжкина, Е. В. Третьяков et al. · Современные проблемы науки и образования · 2015
To date, bacterial translocation from the intestinal lumen is considered the main mechanism of occurrence of septic complications of pancreatic necrosis aseptic. We believe that to improve the barrier properties of the intestinal mucosa is necessary rectal immunomodulator. The study included two groups of patients. The study group consisted of patients receiving standard therapy and immunomodulator Derinat which was administered rectally. The comparison group consisted of patients diagnosed with pancreatic aseptic who received standard therapy. We analyzed the clinical results included in the complex therapy of pancreatic necrosis aseptic rectal immunomodulator Derinat. Based on these data, it was shown to reduce the number of infected pancreatic necrosis forms, reducing the number of surgical interventions, reducing mortality.
Cited by 0 works.